Technical Analysis for IPCI - Intellipharmaceutics International Inc

Grade Last Price % Change Price Change
grade D 0.295 5.32% 0.0149
IPCI closed up 5.32 percent on Friday, January 25, 2019, on 65 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical IPCI trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Volume Surge Other 1.20%
Hot IPO Pullback Bullish Swing Setup 9.30%
Doji - Bullish? Reversal 9.30%
Down 3 Days in a Row Weakness 9.30%
Gapped Down Weakness 9.30%
Hot IPO Pullback Bullish Swing Setup -43.27%
Gapped Down Weakness -43.27%

Older signals for IPCI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
IntelliPharmaCeutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada. It develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Oxycodone ER, an abuse deterrent oxycodone hydrochloride extended release tablets; Regabatin and Lyrica pregabalin extended-release capsules for the management of neuropathic pain; Effexor XR, an extended-release capsule for oral administration to treat depression; Protonix, a delayed-release capsule for oral administration to treat gastroesophageal reflux disease; and Glucophage XR, a drug that treats type 2 diabetes. It also provides Seroquel XR, an oral psychotropic agent for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; Lamictal XR, an anticonvulsant drug to terat epilepsy; Keppra XR, an antiepileptic drug for the treatment of partial onset seizures in patients with epilepsy; Pristiq, a selective serotonin and norepinephrine reuptake inhibitor to treat major depressive disorder; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company provides Focalin XR, an extended-release capsule for hyperactivity disorder. It has has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.
RTT Pharmaceutical Drugs Diabetes Pain Psychoactive Drugs Chemical Compounds Hypertension Depression Epilepsy Heart Failure Oxycodone Drug Delivery Systems Schizophrenia Major Depressive Disorder Bipolar Disorder Hyperactivity Disorder
Is IPCI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 3.0
52 Week Low 0.25
Average Volume 262,845
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 1.0233
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3474
Resistance 3 (R3) 0.3465 0.3282 0.3386
Resistance 2 (R2) 0.3282 0.3149 0.3286 0.3357
Resistance 1 (R1) 0.3116 0.3066 0.3199 0.3125 0.3328
Pivot Point 0.2933 0.2933 0.2975 0.2937 0.2933
Support 1 (S1) 0.2767 0.2800 0.2850 0.2776 0.2572
Support 2 (S2) 0.2584 0.2717 0.2588 0.2543
Support 3 (S3) 0.2418 0.2584 0.2514
Support 4 (S4) 0.2427